These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31571868)

  • 1. Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.
    Liu Z; Ran H; Wang Z; Zhou S; Wang Y
    Int J Nanomedicine; 2019; 14():7627-7642. PubMed ID: 31571868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
    Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
    Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
    [No Abstract]   [Full Text] [Related]  

  • 4. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
    Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
    Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cleverly Designed Novel Lipid Nanosystem: Targeted Retention, Controlled Visual Drug Release, and Cascade Amplification Therapy for Mammary Carcinoma in vitro.
    Zhao XZ; Zhang W; Cao Y; Huang SS; Li YZ; Guo D; Wang XY; Ran HT
    Int J Nanomedicine; 2020; 15():3953-3964. PubMed ID: 32581539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
    Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.
    Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y
    Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Release from Gelsolin-Targeted Phase-Transition Nanoparticles Triggered by Low-Intensity Focused Ultrasound.
    Qin H; Teng R; Liu Y; Li J; Yu M
    Int J Nanomedicine; 2022; 17():61-71. PubMed ID: 35023919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
    Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
    Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.
    Zhang N; Wang R; Hao J; Yang Y; Zou H; Wang Z
    Int J Nanomedicine; 2017; 12():7273-7289. PubMed ID: 29042775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy.
    Zhao X; Luo W; Hu J; Zuo L; Wang J; Hu R; Wang B; Xu L; Li J; Wu M; Li P; Liu L
    J Nanobiotechnology; 2018 Mar; 16(1):36. PubMed ID: 29602311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
    Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
    Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
    Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
    Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
    Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
    Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-Loaded Nanoparticles with Low-Intensity Focused Ultrasound-Induced Phase Transformation as Tumor-Targeted and pH-Sensitive Theranostic Nanoplatform of Ovarian Cancer.
    Guo X; Mei J; Jing Y; Wang S
    Nanoscale Res Lett; 2020 Apr; 15(1):73. PubMed ID: 32266591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of doxorubicin-gated mesoporous polydopamine nanoplatforms for multimode imaging-guided synergistic chemophotothermal therapy of tumors.
    Yang M; Zhang N; Zhang T; Yin X; Shen J
    Drug Deliv; 2020 Dec; 27(1):367-377. PubMed ID: 32091284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer.
    Dong Q; Wan C; Yang H; Zheng D; Xu L; Zhou Z; Xie S; Du J; Li F
    J Biomater Appl; 2020 Sep; 35(3):430-445. PubMed ID: 32515640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.